Skip to main content
. 2024 Jul 3;16(7):4229–4237. doi: 10.21037/jtd-23-1736

Table 3. PFT findings of PM/DM associated ILD patients according to the relapse status.

Item Relapse group (n=36) Non-relapse group (n=38) P value
FVC (L) 2.01 (1.19–3.48) 1.73 (0.95–2.78) 0.17
%FVC (%) 76.1 (60.7–100.6) 70.6 (44.8–113.2) 0.41
TLC (L) 3.89 (3.15–5.69) 3.22 (2.27–4.88) 0.10
%TLC (%) 90.9 (81–106.8) 82.2 (49.3–126.8) 0.36
%DLco (%) 94.8 (48.8–192.3) 60.7 (33.2–101.3) 0.11

Data are expressed as median (minimum to maximum). PM, polymyositis; DM, dermatomyositis; PFT, pulmonary function test; ILD, interstitial lung disease; FVC, forced vital capacity; %FVC, percent predicted forced vital capacity; TLC, total lung capacity; %TLC, percent predicted total lung capacity; %DLco, percent predicted diffusing capacity for carbon dioxide.